Last edition
News about "Tillotts Pharma"
Tillotts Pharma AG Celebrates 15 Years Anniversary as Part of Japanese Zeria Group
This commitment has also led to Tillotts in-licensing the product Dificlir™ for the treatment of Clostridioides difficile infection (CDI) in 2020, a potentially life-threatening disease.
Tillotts Pharma | 14/02/2025 | By Aishwarya
Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
Tillotts Pharma | 21/07/2023 | By Sudeep Soparkar | 513
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy